Bob S. Carter, MD, PhD, is a board-certified neurosurgeon specializing in complex intracranial surgery including brain, pituitary, and skull base tumors, and brain aneurysms.

Dr. Carter is the Chair of the Department of Neurosurgery at Mass General and Visiting Professor at Harvard Medical School. One of the nation’s leading clinical neurosurgeons, Dr. Carter co-leads Massachusetts General Hospital’s brain tumor program, which brings together over 100 faculty and staff focused on brain tumor clinical care, research and education.

As a prolific researcher, Dr. Carter's scientific work has included the development of the first reported EGFRvIII directed CAR T-cell therapy, and the first characterizations of exosomes in glioblastoma.  He is a principal investigator participating in the NIH-funded Extracellular RNA Communication Consortium. Dr. Carter leads a team of clinician scientists who have developed the role of “big data” in characterizing outcomes in oncologic and vascular neurosurgery.

Dr. Carter is extensively published, and he lectures internationally on neurosurgery topics. He is an editorial board member for the Journal of Neurosurgery and editorial advisory board member for Neurosurgery.